Garner Elizabeth Insider Trades

Insider Trading History

Track insider trading activity for Garner Elizabeth. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $0 0 shares
Last Trade
May 11, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$117k 16,100 shares
$7.29
$7.29
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $36.5k 5,000 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.3k 5,000 shares
$4.46
$7.29
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $365k 50,000 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$331k 50,000 shares
$6.62
$7.29
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $190k 26,000 shares
Last Trade
Jul 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 52,689 shares
$22.80
$7.29
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $0 0 shares
Last Trade
Jul 24, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.79M 78,689 shares
$22.80
$7.29
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $255k 35,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$924k 35,000 shares
$26.40
$7.29
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $190k 26,000 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.5M 52,000 shares
$48.00
$7.29
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $190k 26,000 shares
Last Trade
Jun 28, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.45M 26,000 shares
$55.90
$7.29
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $64.9k 8,896 shares
Last Trade
Jun 24, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$498k 8,896 shares
$56.00
$7.29
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $130k 17,793 shares
Last Trade
Dec 18, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$539k 17,793 shares
$30.30
$7.29
Agile Therapeutics
Agile Therapeutics AGRX
Sr. VP & Chief Medical Officer
Holding Value $261k 172,600 shares
Last Trade
Jan 29, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.6B 211,100 shares
$83,564.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Sr. VP & Chief Medical Officer
Holding Value $72.2k 47,800 shares
Last Trade
Jan 25, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.49B 17,500 shares
$84,900.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Sr. VP & Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Jan 25, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.49B 17,500 shares
$84,900.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Sr. VP & Chief Medical Officer
Holding Value $45.8k 30,300 shares
Last Trade
Jan 24, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.65B 18,565 shares
$88,640.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Sr. VP & Chief Medical Officer
Holding Value $26.4k 17,500 shares
Last Trade
Jan 24, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.65B 18,565 shares
$88,640.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Sr. VP & Chief Medical Officer
Holding Value $227k 150,000 shares
Last Trade
Jun 20, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.65B 150,000 shares
$57,680.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Sr. VP & Chief Medical Officer
Holding Value $17.7k 11,735 shares
Last Trade
Jan 25, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.91B 5,765 shares
$332,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Sr. VP & Chief Medical Officer
Holding Value $54.5k 36,065 shares
Last Trade
Jan 25, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11.6B 35,000 shares
$332,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Sr. VP & Chief Medical Officer
Holding Value $162k 107,000 shares
Last Trade
Jan 24, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.4B 125,565 shares
$346,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Sr. VP & Chief Medical Officer
Holding Value $151k 100,000 shares
Last Trade
Jan 25, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.5B 135,000 shares
$226,000.00
$1.51

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up